Literature DB >> 29893126

Triple Stimuli-Responsive Magnetic Hollow Porous Carbon-Based Nanodrug Delivery System for Magnetic Resonance Imaging-Guided Synergistic Photothermal/Chemotherapy of Cancer.

Fan Wu1, Ming Zhang2,3, Hanwen Lu1, Dong Liang1, Yaliang Huang1, Yonghong Xia1, Yuqing Hu1, Shengqiang Hu1, Jianxiu Wang1, Xinyao Yi1, Jun Zhang2,3.   

Abstract

The premature leakage of anticancer drugs during blood circulation may the damage immune system, normal cells, and tissues. Constructing targeted nanocarriers with pH, glutathione, and NIR triple-responsive property can effectively avoid the leakage of anticancer drugs before they arrive at the targeted site. In this paper, magnetic hollow porous carbon nanoparticles (MHPCNs) were successfully fabricated as nanocarrier. Poly(γ-glutamic acid) was used to cap the pores of MHPCNs. The photothermal conversion property of carbon and iron oxide (Fe3O4) nanomaterials was utilized to perform photothermal therapy to overcome multidrug-resistance produced by chemotherapy. The biodistribution of nanoparticles was investigated by magnetic resonance imaging. Experiments in vivo confirm the efficient accumulations of nanoparticles at tumor sites. Meanwhile, tumor growth was effectively inhibited via synergistic photothermal/chemotherapy with minimal side effects.

Entities:  

Keywords:  MHPCNs; MR imaging; PGA; synergistic photothermal/chemo-therapy; triple-responsive

Mesh:

Substances:

Year:  2018        PMID: 29893126     DOI: 10.1021/acsami.8b07213

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  18 in total

Review 1.  Manganese-based hollow nanoplatforms for MR imaging-guided cancer therapies.

Authors:  Shuang Liang; Guangfu Liao; Wenzhen Zhu; Li Zhang
Journal:  Biomater Res       Date:  2022-07-06

2.  Synergistic Treatment of Tumor by Targeted Biotherapy and Chemotherapy via Site-Specific Anchoring of Aptamers on DNA Nanotubes.

Authors:  Run Chen; Pengchao Sun; Xiao Chu; Xiaorong Pu; Yang Yang; Nan Zhang; Yongxing Zhao
Journal:  Int J Nanomedicine       Date:  2020-02-27

3.  Recent advances in porous nanostructures for cancer theranostics.

Authors:  Jinping Wang; Beilu Zhang; Jingyu Sun; Wei Hu; Hongjun Wang
Journal:  Nano Today       Date:  2021-04-08       Impact factor: 18.962

4.  Polydopamine-modified dual-ligand nanoparticles as highly effective and targeted magnetic resonance/photoacoustic dual-modality thrombus imaging agents.

Authors:  Yu Zhang; Yixin Zhong; Man Ye; Jie Xu; Jia Liu; Jun Zhou; Shike Wang; Dajing Guo; Zhigang Wang; Haitao Ran
Journal:  Int J Nanomedicine       Date:  2019-09-03

5.  Meta-Analysis of Nanoparticle Delivery to Tumors Using a Physiologically Based Pharmacokinetic Modeling and Simulation Approach.

Authors:  Yi-Hsien Cheng; Chunla He; Jim E Riviere; Nancy A Monteiro-Riviere; Zhoumeng Lin
Journal:  ACS Nano       Date:  2020-03-04       Impact factor: 15.881

6.  Biodistribution, Clearance And Morphological Alterations Of Intravenously Administered Iron Oxide Nanoparticles In Male Wistar Rats.

Authors:  Usha Singh Gaharwar; Ramovatar Meena; Paulraj Rajamani
Journal:  Int J Nanomedicine       Date:  2019-12-06

Review 7.  Stimuli-Responsive Iron Oxide Nanotheranostics: A Versatile and Powerful Approach for Cancer Therapy.

Authors:  Morgan E Lorkowski; Prabhani U Atukorale; Ketan B Ghaghada; Efstathios Karathanasis
Journal:  Adv Healthc Mater       Date:  2020-11-23       Impact factor: 9.933

Review 8.  Hollow structures as drug carriers: Recognition, response, and release.

Authors:  Decai Zhao; Nailiang Yang; Lekai Xu; Jiang Du; Yang Yang; Dan Wang
Journal:  Nano Res       Date:  2021-07-08       Impact factor: 8.897

Review 9.  Recent Advances in Stimulus-Responsive Nanocarriers for Gene Therapy.

Authors:  Cheng Yu; Long Li; Pei Hu; Yan Yang; Wei Wei; Xin Deng; Lu Wang; Franklin R Tay; Jingzhi Ma
Journal:  Adv Sci (Weinh)       Date:  2021-05-16       Impact factor: 16.806

Review 10.  Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics.

Authors:  Peng Mi
Journal:  Theranostics       Date:  2020-03-15       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.